Nephrolithiasis: Evaluation and management

Southern Medical Journal

Volumn 104, Issue 2, 2011, Pages 133-139

  Brener, Zachary Z ^a   Winchester, James F ^a   Salman, Hertzel ^a   Bergman, Michael ^a  

^a NONE

Author keywords

calcium; lithotripsy; nephrolithiasis; renal stones

Indexed keywords

ACETOHYDROXAMIC ACID; ALLOPURINOL; BICARBONATE; CALCIUM; CALCIUM OXALATE; CHLORTALIDONE; CITRATE POTASSIUM; CREATININE; CYSTINE; ELECTROLYTE; HYDROCHLOROTHIAZIDE; INDINAVIR; NONSTEROID ANTIINFLAMMATORY AGENT; OXALIC ACID; PARATHYROID HORMONE; PENICILLAMINE; POTASSIUM SPARING DIURETIC AGENT; PURINE; SODIUM; STRUVITE; TAMSULOSIN; TIOPRONIN; TRIAMTERENE; URIC ACID;

ANTIBIOTIC THERAPY; APPENDICITIS; AUTOSOMAL RECESSIVE DISORDER; AWARENESS; CALCIUM INTAKE; CALCIUM OXALATE STONE; CALCIUM URINE LEVEL; CHOLECYSTITIS; CHRONIC DISEASE; CLINICAL EVALUATION; COLON RESECTION; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; CYSTINE STONE; CYSTINURIA; DIABETES MELLITUS; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DIVERTICULITIS; ECHOGRAPHY; ENTERITIS; ERADICATION THERAPY; EXTRACORPOREAL LITHOTRIPSY; FALSE NEGATIVE RESULT; FAMILY HISTORY; FLANK PAIN; FLUID INTAKE; FOLLOW UP; GENETIC DISORDER; GOLD STANDARD; GYNECOLOGIC DISEASE; HAEMOPHILUS; HEALTH CARE COST; HEMATURIA; HERPES ZOSTER; HIGH SODIUM INTAKE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCALCEMIA; HYPERCALCIURIA; HYPEROXALURIA; HYPERPARATHYROIDISM; HYPERTENSION; HYPERURICOSURIA; HYPOCITRATURIA; IDIOPATHIC DISEASE; INCIDENCE; INTRAVENOUS PYELOGRAPHY; KIDNEY COLIC; KIDNEY DISEASE; KIDNEY INFARCTION; KIDNEY PAPILLA NECROSIS; KLEBSIELLA; MALABSORPTION; METABOLIC ACIDOSIS; MORBIDITY; MORTALITY; MUSCULOSKELETAL PAIN; NEOPLASM; NEPHROLITHIASIS; PARATHYROID HORMONE BLOOD LEVEL; PATHOPHYSIOLOGY; PATIENT EDUCATION; PERCUTANEOUS NEPHROLITHOTOMY; PERSISTENT INFECTION; PHYSICAL EXAMINATION; PROTEIN DIET; PROTEUS; PYELONEPHRITIS; REVIEW; RISK REDUCTION; SARCOIDOSIS; SODIUM RESTRICTION; STRUVITE STONE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UREAPLASMA UREALYTICUM; URETEROLITHOTOMY; URIC ACID STONE; URINALYSIS; URINARY EXCRETION; URINARY TRACT INFECTION; URINE PH; URINE VOLUME; UROLITHIASIS;

FEMALE; HUMANS; KIDNEY CALCULI; MALE; NEPHROLITHIASIS; UNITED STATES;

EID: 79251586848     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318206f6bd     Document Type: Review

References (38)

1. Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol 2000;13(suppl 3): S45-S50.
2. Curhan GC, Rimm EB, Willett WC, et al. Regional variation in nephrolithiasis incidence and prevalence among United States men. J Urol 1994;151:838-841.
3. Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003;63:1817-1823.
4. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA 2005;293:455-462.
5. Taylor EN, Curhan GC. Differences in 24-hour urine composition between black and white women. J Am Soc Nephrol 2007;18:654-659.
6. Hall PM. Nephrolithiasis: treatment, causes and prevention. Cleve Clin J Med 2009;76:583-591.
7. Moe OW. Kidney stones: pathophysiology and medical management. Lancet 2006;367:333-344.
8. Coe FL, Parks JH. Pathogenesis and treatment of nephrolithiasis, in The Kidney. Philadelphia, Lippincott Williams & Wilkins, 2000, pp 1841-1867.
9. Chow K, Dixon J, Gilpin S, et al. Citrate inhibits growth of residual fragments in an in vitro model of calcium oxalate renal stones. Kidney Int 2004;65:1724-1730.
10. Coe FL, Favus MJ, Pak CY, et al. Kidney Stones: Medical and Surgical Management. Philadelphia, Lippincott Williams & Wilkins, 1996.
11. Brennan S, Hering-Smith K, Hamm LL. Effect of pH on citrate reabsorption in the proximal convoluted tubule. Am J Physiol 1988;255: F301-F306.
12. Meschi T, Schianchi T, Ridolo E, et al. Body weight, diet and water intake in preventing stone disease. Urol Int 2004;72:29-33.
13. Heller HJ, Doerner MF, Brinkley LJ, et al. Effect of dietary calcium on stone forming propensity. J Urol 2003;169:470-474.
14. Curhan GC, Willett WC, Knight EL, et al. Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Int Med 2004;164:885-891.
15. Domrongkitchaiporn S, Sopassathit W, Stitchantrakul W, et al. Schedule of taking calcium supplement and the risk of nephrolithiasis. Kidney Int 2004;65:1835-1841.
16. Reddy ST, Wang CY, Sakhaee K, et al. Effect of low-carbohydrate, high-protein diets on acid-base balance, stone forming propensity, and calcium metabolism. Am J Kidney Dis 2002;40:265-274.
17. Kramer HJ, Choi HK, Atkinson K, et al. The association between gout and nephrolithiasis in men: The Health Professionals' Follow-Up Study. Kidney Int 2003;64:1022-1026.
18. Abate N, Chandalia M, Cabo-Chan AV Jr, et al. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 2004;65:386-392.
19. Palacín M, Nunes V, Font-Llitjós M, et al. The genetics of heteromeric amino acid transporters. Physiology (Bethesda) 2005;20:112-124.
20. Griffith DP. Struvite stones. Kidney Int 1978;13:372-382.
21. Fielding JR, Steele G, Fox LA, et al. Spiral computerized tomography in the evaluation of acute flank pain: a replacement for excretory urography. J Urol 1997;157:2071-2073.
22. Fowler KA, Locken JA, Dushesne JH, et al. US for detecting renal calculi with nonenhanced CT as a reference standard. Radiology 2002;222:109-113.
23. Butler EL, Cox SM, Eberts EG, et al. Symptomatic nephrolithiasis complicating pregnancy. Obstet Gynecol 2000;96:753-756.
24. Labrecque M, Dostaler LP, Rousselle R, et al. Efficacy of nonsteroidal anti-inflammatory drugs in the treatment of acute renal colic. A metaanalysis. Arch Intern Med 1994;154:1381-1387.
25. Dellabella M, Milanese G, Muzzonigro G. Randomized trial of the efficacy of tamsulosin, nifedipine, and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol 2005;174:167-172.
26. Goldfarb DS. Reconsideration of the 1988 NIH Consensus Statement on Prevention and Treatment of Kidney Stones: are the recommendations out of date? Rev Urol 2002;4:53-60.
27. Burtis WJ, Gay L, Insogna KL, et al. Dietary hypercalciuria in patients with calcium oxalate kidney stones. Am J Clin Nutr 1994;60:424-429.
28. Hess B, Ackermann D, Essig M, et al. Renal mass and serum calcitriol in male idiopathic calcium renal stone formers: role of protein intake. J Clin Endocrinol Metab 1995;80:1916-1921.
29. Coe FL, Parks JH, Bushinsky DA, et al. Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int 1988;33:1140-1146.
30. Ettinger B, Tang A, Citron JT, et al. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 1986;315:1386-1389.
31. Sakhaee K. Pathogenesis and medical; management of cystinuria. Semin Nephrol 1996;16:435-447.
32. Shekarriz B, Stoller ML. Cystinuria and other noncalcareous calculi. Endocrinol Metab Clin North Am 2002;31:951-977.
33. Griffith DP, Gibson JR, Clinton CW, et al. Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi. J Urol 1978;119:9-15.
34. Samplaski MK, Irwin BH, Desai M. Less-invasive ways to remove stones from the kidneys and ureters. Cleve Clin J Med 2009;76:592-598.
35. Glowacki LS, Beecroft ML, Cook RJ, et al. The natural history of asymptomatic urolithiasis. J Urol 1992;147:319-321.
36. Inci K, Sahin A, Islamoglu E, et al. Prospective long-term follow-up of patients with asymptomatic lower pole calyceal stones. J Urol 2007;177:2189-2192.
37. Abdel-Khalek M, Sheir KZ, Mokhtar AA, et al. Prediction of success rate after extracorporeal shock-wave lithotripsy of renal stones - a multivariate analysis model. Scand J Urol Nephrol 2004;38:161-167.
38. Krambeck AE, Gettman MT, Rohlinger AL, et al. Diabetes mellitus and hypertension associated with shock wave lithotripsy of renal and proximal ureteral stones at 19 years of followup. J Urol 2006;175:1742-1747.